Large for Gestational Age (Macrosomia)

1. Clinical Overview

Summary

Large for Gestational Age (LGA) is defined as a fetal or neonatal weight exceeding the 90th centile for gestational age on standardized growth charts. Macrosomia is defined by absolute birthweight thresholds, typically > 4000g or > 4500g, though these cutoffs vary internationally. [1,2]

The predominant underlying mechanism in pathological LGA is maternal hyperglycaemia, which drives fetal hyperinsulinaemia and excessive somatic growth through the Pedersen hypothesis. However, constitutional factors (genetic, ethnic, paternal size) account for the majority of LGA cases in non-diabetic populations. [3]

The principal clinical concern is shoulder dystocia, occurring when the bisacromial diameter exceeds the pelvic outlet capacity, resulting in impaction of the anterior shoulder behind the pubic symphysis. This obstetric emergency carries risks of permanent brachial plexus injury (Erb's or Klumpke's palsy), clavicular fracture, hypoxic-ischaemic encephalopathy, and maternal perineal trauma. [4,5]

Neonatal complications include hypoglycaemia (from abrupt cessation of transplacental glucose supply despite persistent fetal hyperinsulinaemia), polycythaemia, hyperbilirubinaemia, and respiratory distress. Long-term metabolic programming effects increase childhood obesity and adult metabolic syndrome risk. [6,7]

Key Definitions

Clinical Pearls

The "Diabetic Shoulder": In constitutional (non-diabetic) macrosomia, fetal growth is proportionate across all body segments. In diabetic macrosomia, insulin-mediated adipogenesis occurs preferentially in insulin-sensitive tissues—trunk, shoulders, and liver—while insulin-independent tissues (brain, long bones) grow normally. Thus, a 4000g infant of a diabetic mother has disproportionately enlarged shoulders relative to head size, conferring substantially higher shoulder dystocia risk than a constitutionally large 4000g infant. This explains why EFW thresholds for intervention are lower in diabetic pregnancies (4500g vs 5000g). [8]

Turtle Sign: The pathognomonic sign of shoulder dystocia. After delivery of the head, it retracts tightly against the perineum between contractions (resembling a turtle withdrawing into its shell). This occurs because the neck is stretched and tethered by the impacted shoulders within the pelvis. Recognition triggers immediate activation of shoulder dystocia protocol (HELPERR mnemonic) and calls for senior assistance. [9]

Beckwith-Wiedemann Syndrome (BWS): An imprinting disorder characterized by the triad of macrosomia, macroglossia (enlarged tongue), and abdominal wall defects (omphalocele, umbilical hernia). Additional features include ear pits/creases, hemihypertrophy, and neonatal hypoglycaemia. BWS patients have 7.5% lifetime risk of embryonal tumours (Wilms' nephroblastoma, hepatoblastoma) requiring surveillance abdominal ultrasound every 3 months until age 7 years. Consider genetic testing for LGA + syndromic features. [10]

Abdominal Circumference (AC) Supremacy: Among ultrasound biometric parameters, AC is the single best predictor of diabetic macrosomia. In diabetic fetuses, the head circumference (HC) and femur length (FL) are typically normal (as brain and bone are insulin-independent), while AC reflects hepatomegaly (glycogen deposition) and truncal adiposity. An AC > 90th centile with normal HC produces low HC/AC ratio, suggesting asymmetric diabetic overgrowth. Conversely, symmetric elevation of all parameters suggests constitutional large size. [11]

---

2. Epidemiology

Demographics and Incidence

• Overall Incidence: By definition, 10% of all neonates are LGA (> 90th centile). [1]
• Macrosomia > 4000g: 5-10% of deliveries in developed nations; rising due to obesity epidemic. [12]
• Macrosomia > 4500g: 1-2% of deliveries. [12]
• Temporal Trends: Average birthweight increased by ~200g between 1970-2010 in high-income countries, attributed to maternal obesity and gestational diabetes prevalence. [13]

Risk Factors

Maternal Factors

Fetal Factors

• Male Fetus: 150-200g heavier than female fetuses on average (RR 1.3-1.5). [14]
• Genetic Syndromes: Beckwith-Wiedemann, Sotos syndrome, Weaver syndrome, Perlman syndrome.
• Fetal Hyperinsulinaemia: Central driver in diabetic macrosomia.

Ethnic Variation

• Higher Rates: Hispanic, Pacific Islander, Indigenous populations (related to diabetes prevalence and genetic factors). [15]
• Lower Rates: Asian populations (lower birthweight distributions). [15]

Protective Factors

• Maternal Smoking: Paradoxically reduces LGA risk (but increases SGA/IUGR risk; never therapeutic).
• Maternal Chronic Hypertension: Placental insufficiency mitigates overgrowth.
• Maternal Malnutrition: Nutrient restriction.

---

3. Pathophysiology

The Pedersen Hypothesis: Hyperglycaemia-Hyperinsulinaemia Paradigm

The Pedersen hypothesis, proposed in 1952, remains the cornerstone explanation for diabetic macrosomia: [16]

1. Maternal Hyperglycaemia: Elevated maternal blood glucose (from pre-existing diabetes, gestational diabetes, or impaired glucose tolerance).

2. Transplacental Glucose Transfer: Glucose crosses the placenta via facilitated diffusion through GLUT1 and GLUT3 transporters. Transfer is concentration-dependent—higher maternal glucose drives higher fetal glucose.

3. Maternal Insulin Does Not Cross: Insulin is a large peptide hormone that does not cross the placental barrier. Therefore, maternal insulin therapy controls maternal glycaemia but does not directly affect the fetus.

4. Fetal Pancreatic Response: The fetal pancreas detects hyperglycaemia and upregulates insulin secretion from β-cells (which mature by 12 weeks gestation). Fetal hyperinsulinaemia develops.

5. Insulin as Anabolic Growth Factor: Insulin promotes:

   • Lipogenesis: Adipose tissue deposition, particularly truncal and subcutaneous.
   • Glycogen Storage: Hepatomegaly (enlarged liver), cardiomegaly (myocardial glycogen).
   • Protein Synthesis: Increased lean body mass.
   • IGF-1 Mediation: Insulin stimulates IGF-1 production, amplifying anabolic effects.

6. Selective Tissue Growth: Insulin-sensitive tissues (liver, heart, adipose, skeletal muscle) hypertrophy disproportionately. Insulin-independent tissues (brain, skeleton) grow normally. This produces the characteristic diabetic macrosomia phenotype: organomegaly with normal head size and long bone length. [8]

Neonatal Metabolic Consequences

At Birth: Glucose-Insulin Mismatch

• In Utero: High transplacental glucose + high fetal insulin = anabolism.
• Post-Delivery: Cord clamping abruptly terminates glucose supply. However, the fetal pancreas remains hyperactive (pancreatic β-cell hyperplasia persists).
• Result: Unopposed hyperinsulinaemia causes profound neonatal hypoglycaemia within 30-60 minutes of birth. [6]

Polycythaemia Mechanism

• Fetal hyperinsulinaemia increases metabolic rate and oxygen consumption.
• Relative tissue hypoxia stimulates erythropoietin (EPO) production.
• Increased red blood cell mass → polycythaemia (venous haematocrit > 65%).
• Complications: Hyperviscosity syndrome (poor perfusion, thrombosis), hyperbilirubinaemia (haemolysis). [7]

Constitutional (Non-Diabetic) Macrosomia

In non-diabetic pregnancies, LGA results from:

• Genetic Potential: Parental size (tall, large parents).
• Ethnic Background: Population-specific growth curves.
• Optimal Placental Function: Efficient nutrient transfer without metabolic pathology.
• Male Sex: Androgen-mediated growth advantage.

Constitutional LGA exhibits:

• Symmetrical Growth: All biometric parameters (HC, AC, FL) proportionately elevated.
• Normal Body Composition: Appropriate adiposity without organomegaly.
• Lower Complication Risk: Reduced shoulder dystocia risk compared to diabetic macrosomia of equivalent weight. [8]

Molecular Pathophysiology

Insulin Signaling Cascade:

• Insulin binds insulin receptor (tyrosine kinase).
• Activates PI3K/Akt pathway → GLUT4 translocation (glucose uptake).
• Activates mTOR pathway → protein synthesis.
• Inhibits FOXO transcription factors → reduced gluconeogenesis.

IGF-1 Synergy: Insulin upregulates IGF-1 and IGF-1 receptors, amplifying growth signaling.

Placental Nutrient Sensing: In maternal obesity/diabetes, placental nutrient sensors (mTOR, AMPK) are dysregulated, increasing amino acid and lipid transfer independent of glucose. [17]

---

4. Clinical Presentation

Antenatal Presentation

History

• Risk Factor Identification:
  • Previous macrosomic infant.
  • Diabetes (pre-existing or gestational).
  • Obesity or excessive weight gain.
  • Family history of large babies.
  • Post-dates pregnancy.

Maternal Symptoms

• Fundal Height Discrepancy: Symphysis-fundal height (SFH) measuring > 3cm above expected for gestational age (GA).
  • "Caveat: SFH has poor sensitivity/specificity for LGA (affected by maternal habitus, fetal position, liquor volume, fibroids). [18]"
• Dyspnoea: Mechanical compression from large uterus.
• Reduced Mobility: Abdominal discomfort.
• Polyhydramnios: Often coexists (fetal polyuria from hyperglycaemia-induced osmotic diuresis).

Clinical Examination

• Leopold's Maneuvers:

  • "First Maneuver (Fundal Palpation): High fundal height."
  • "Second Maneuver (Lateral Palpation): Large fetal parts."
  • "Third Maneuver (Pelvic Grip): Large presenting part; may remain high despite term gestation."
  • "Fourth Maneuver (Pelvic Brim): Difficulty engaging head."

• Symphysis-Fundal Height (SFH): Measured in cm from pubic symphysis to uterine fundus (with patient supine, bladder empty). Normally approximates gestational age in weeks (±3cm). > 3cm discrepancy warrants ultrasound assessment. [1]

Ultrasound Assessment

Biometric Parameters

EFW Accuracy Limitations

• Error Margin: ±15% (2 standard deviations) at term. [11]
  • "Example: EFW 4000g could represent actual weight 3400-4600g."
• Implications: A 4500g threshold includes many fetuses less than 4000g and excludes some > 5000g.
• Sensitivity: 60-65% for detecting macrosomia > 4000g (i.e., misses 35-40% of cases). [3]
• Specificity: 85-90% (low false-positive rate). [3]

Other Ultrasound Features

• Polyhydramnios: AFI > 25cm or single deepest pocket > 8cm.
• Hepatomegaly: Liver span measurement.
• Subcutaneous Fat: Thickened abdominal wall.
• Placental Appearance: Thickened placenta (> 4cm) in diabetic pregnancies.

Intrapartum Presentation

First Stage of Labour

• Prolonged Latent Phase: Cervix fails to dilate despite regular contractions.
• Prolonged Active Phase: Slow cervical dilatation (less than 0.5cm/hour).
• Mechanism: Cephalopelvic disproportion (CPD); large fetal head fails to descend and exert dilating pressure on cervix.

Second Stage of Labour

• Prolonged Descent: Fetal head remains high despite full dilatation and pushing.
• Failure to Descend: Absolute obstruction.
• Shoulder Dystocia: After head delivery, anterior shoulder impacts behind pubic symphysis.
  • "Turtle Sign: Head retracts against perineum."
  • "Failed Gentle Traction: Routine downward traction does not deliver shoulders."

Maternal Signs During Labour

• Caput and Moulding: Excessive caput succedaneum and moulding may suggest CPD.
• Failure of Engagement: Head remains 4/5 or 5/5 palpable abdominally at term.

Neonatal Presentation

Immediate Examination (Delivery Room)

• Large Birthweight: > 4000g or > 4500g.
• Plethora: Ruddy, reddish appearance (polycythaemia).
• Cushingoid Appearance: Round facies, truncal obesity.
• Organomegaly: Hepatomegaly (palpable liver edge).

Birth Trauma

• Brachial Plexus Injury:
  • Erb's Palsy (C5-C6): "Waiter's tip" position—shoulder adducted, elbow extended, forearm pronated, wrist flexed. Loss of shoulder abduction, elbow flexion, forearm supination. Preserved grasp reflex.
  • Klumpke's Palsy (C8-T1): "Claw hand"—intrinsic hand muscle paralysis. Loss of grasp reflex. May have Horner's syndrome (ptosis, miosis, anhidrosis) if T1 involved.
  • "Total Plexus Palsy (C5-T1): Flaccid, insensate arm."
• Clavicular Fracture: Crepitus, asymmetric Moro reflex, localized swelling.
• Humeral Fracture: Rare; pseudo-paralysis of arm.

Metabolic Complications

• Hypoglycaemia: Blood glucose less than 2.0 mmol/L in first 24 hours (or less than 2.5 mmol/L by some criteria). [6]
  • "Timing: Typically 30-60 minutes post-delivery."
  • "Symptoms: Jitteriness, lethargy, hypotonia, poor feeding, apnoea, seizures."
• Polycythaemia: Venous haematocrit > 65%.
  • "Hyperviscosity Symptoms: Plethora, respiratory distress, hypoglycaemia, seizures."
• Hypocalcaemia: Calcium less than 2.0 mmol/L; presents with jitteriness, seizures.
• Hypomagnesaemia: Often accompanies hypocalcaemia.
• Hyperbilirubinaemia: Exaggerated physiological jaundice from polycythaemia and haemolysis.

Respiratory Complications

• Transient Tachypnoea of Newborn (TTN): Delayed clearance of fetal lung fluid.
• Respiratory Distress Syndrome (RDS): Surfactant deficiency (insulin inhibits surfactant production; diabetic macrosomia has delayed lung maturation despite size). [7]

---

5. Investigations

Antenatal Screening and Diagnosis

Diabetes Screening

All pregnant women should undergo screening for gestational diabetes: [19]

Earlier Screening Indications (16-18 weeks or booking):

• BMI > 30 kg/m².
• Previous GDM.
• Previous macrosomic infant (> 4500g).
• Family history of diabetes (first-degree relative).
• High-risk ethnicity (South Asian, Black Caribbean, Middle Eastern).

Ultrasound Growth Surveillance

Indications for Serial Growth Scans (every 2-4 weeks from 28 weeks):

• Confirmed gestational diabetes.
• Pre-existing diabetes (Type 1, Type 2).
• Previous macrosomic infant.
• Maternal BMI > 35 kg/m².
• SFH > 90th centile or > 3cm above expected.
• Polyhydramnios.

Scans Performed:

• Measurement of AC, HC, FL, EFW.
• Plotting on customized or population growth charts.
• Assessment of amniotic fluid index (AFI).
• Umbilical artery Doppler (usually normal in LGA unless placental pathology).

Diagnostic Criteria:

• LGA: EFW or AC > 90th centile.
• Macrosomia: EFW > 4000g or > 4500g.

Limitations: Acknowledged ±15% error margin; clinical context essential. [3,11]

Intrapartum Monitoring

Continuous Electronic Fetal Monitoring (EFM)

• Indication: Macrosomia is a risk factor for fetal compromise; continuous CTG recommended during labour. [20]
• Rationale: Increased risk of cord compression, prolonged labour, intrapartum hypoxia.

Maternal Glucose Monitoring

• In diabetic women: hourly capillary blood glucose during labour (target 4-7 mmol/L). Insulin infusion if required. [19]

Neonatal Investigations

Immediate Postnatal (All LGA/Macrosomic Infants)

1. Blood Glucose Monitoring: [6]

   • Timing: Within 30 minutes of birth (pre-first feed), then pre-feeds for 12-24 hours.
   • Method: Capillary blood glucose (heel prick).
   • Target: Maintain > 2.0-2.5 mmol/L.
   • Action: If less than 2.0 mmol/L, feed immediately; recheck. If persistent or less than 1.4 mmol/L, IV dextrose infusion.

2. Full Blood Count (FBC):

   • Haematocrit: Detect polycythaemia (> 65%).
   • Haemoglobin: May be elevated.

3. Clinical Examination:

   • Clavicles: Palpate for crepitus/fracture.
   • Upper Limbs: Assess movement, Moro reflex, grasp reflex (brachial plexus function).
   • Neurological: Tone, reflexes, consciousness level.

If Polycythaemia Identified

• Serum Bilirubin: Baseline (risk of hyperbilirubinaemia).
• Calcium, Magnesium: Hypocalcaemia screen.
• Partial Exchange Transfusion: If Hct > 70% with symptoms (rarely required).

If Dysmorphic Features or Syndromic Concerns

• Genetic Testing: Consider Beckwith-Wiedemann syndrome (methylation studies of chromosome 11p15), Sotos syndrome, etc.
• Ultrasound Abdomen: Screen for Wilms' tumour (BWS surveillance protocol).
• Echocardiography: Hypertrophic cardiomyopathy (diabetic fetopathy).

---

6. Management

Antenatal Management

Risk Stratification

Glycaemic Control in Diabetic Pregnancies

Target Blood Glucose Levels (NICE NG3): [19]

• Fasting: less than 5.3 mmol/L.
• 1-hour postprandial: less than 7.8 mmol/L.
• 2-hour postprandial: less than 6.4 mmol/L.

Treatment Escalation:

1. Diet and Exercise: First-line for GDM.
2. Metformin: Second-line if diet unsuccessful (within 1-2 weeks).
3. Insulin: Third-line (or first-line if fasting glucose > 7.0 mmol/L or significant hyperglycaemia).

Goal: Optimize glucose control to reduce macrosomia risk; however, once LGA established, glycaemic control may not reverse fetal overgrowth. [19]

Timing of Delivery

Key Evidence: The Big Baby Trial (Lancet 2025) [18]

• Design: Multicentre RCT; 824 women with singleton pregnancies and EFW > 90th centile.
• Intervention: Induction of labour at 38 weeks vs expectant management until 40 weeks.
• Primary Outcome: Composite neonatal morbidity (shoulder dystocia, brachial plexus injury, fracture, HIE).
• Results:
  • "Shoulder dystocia: 3.2% (IOL) vs 8.5% (expectant) (OR 0.36, 95% CI 0.18-0.70)."
  • "Caesarean section: No significant difference (20% vs 22%; p=0.58)."
  • "Neonatal fractures: Reduced in IOL group (0.5% vs 2.9%)."
  • "Conclusion: IOL at 38 weeks reduces shoulder dystocia and birth trauma without increasing CS rates. This trial shifted practice toward earlier delivery in suspected macrosomia."

Current Recommendations: [18,19]

• Non-Diabetic, EFW 4000-4499g: IOL at 39-40 weeks (counsel on risks/benefits).
• Non-Diabetic, EFW ≥4500g: IOL at 39 weeks or elective CS (individualized decision based on pelvic assessment, previous obstetric history, patient preference).
• Diabetic, EFW 4000-4499g: IOL at 38-39 weeks.
• Diabetic, EFW ≥4500g: Elective CS recommended (ACOG, RCOG, NICE guidance). [4,5,19]

Rationale: Early delivery prevents further fetal weight gain (100-200g/week at term) and reduces shoulder dystocia risk, without increasing intervention rates. [18]

Elective Caesarean Section Counselling

Indications:

• EFW ≥4500g (diabetic) or ≥5000g (non-diabetic).
• Previous shoulder dystocia with permanent injury.
• Previous 3rd/4th degree tear with large fetus.
• Maternal request after informed consent.

Consent Discussion:

• Risks of vaginal delivery: Shoulder dystocia (10-20% if EFW > 4500g), birth trauma, emergency CS in labour.
• Risks of CS: Surgical risks (bleeding, infection, organ injury), future pregnancy implications (placenta accreta, scar dehiscence), maternal recovery time.
• Acknowledge EFW uncertainty (±15%).

Intrapartum Management

Preparation for Vaginal Delivery

• Senior Obstetrician Presence: Consultant or senior registrar for anticipated macrosomia.
• Anaesthetic Awareness: Inform on-call anaesthetist.
• Neonatal Team Standby: Paediatrician/neonatal team for potential resuscitation and hypoglycaemia management.
• Avoid Instrumental Mid-Cavity Delivery: High risk of impaction and trauma; rotational forceps contraindicated in macrosomia. [5]

Labour Progress

• Active Management: Prompt recognition of labour dystocia (failure to progress).
• Syntocinon Augmentation: Use cautiously; excessive augmentation with CPD risks uterine rupture. Senior review essential if poor progress despite adequate contractions.
• Early Recourse to CS: Lower threshold for intrapartum CS if concerns about CPD or prolonged labour.

Shoulder Dystocia Management: HELPERR Mnemonic [9]

Shoulder dystocia is diagnosed when routine downward traction fails to deliver the shoulders, or additional maneuvers are required. Immediate systematic approach:

Additional Maneuvers (if above fail):

• Zavanelli Maneuver: Replace fetal head into vagina and perform emergency CS (rarely required; high morbidity).
• Symphysiotomy: Surgical division of pubic symphysis (used in low-resource settings without CS access).

Documentation: Detailed contemporaneous notes of timing, maneuvers performed, personnel present, neonatal condition, APGAR scores. Medicolegal scrutiny is high in shoulder dystocia cases.

Neonatal Management

Immediate Care (First Hour)

1. Resuscitation: As per Neonatal Life Support (NLS) guidelines if required.

2. Hypoglycaemia Prevention: [6]

   • Early Feeding: Initiate breastfeeding or formula within 30 minutes of birth.
   • Blood Glucose Monitoring:
     • First measurement at 30 minutes (pre-first feed).
     • Then pre-feeds for 12-24 hours (frequency depends on initial values).
   • Thresholds:
     • less than 2.0 mmol/L: Feed immediately, recheck in 30-60 minutes.
     • less than 1.4 mmol/L or symptomatic: IV dextrose 10% bolus (2-3 mL/kg) + infusion.
     • Persistent hypoglycaemia: Admit to neonatal unit; investigate hyperinsulinism (insulin, C-peptide, ketones, growth hormone, cortisol).

3. Birth Trauma Examination: [5]

   • Clavicles: Palpate for crepitus; if fracture, handle gently (heals spontaneously; supportive care).
   • Brachial Plexus: Assess arm movement, Moro reflex, grasp reflex. If abnormal:
     • Erb's Palsy: Loss of C5/C6 function; physiotherapy referral; most resolve by 3 months; persistent deficits require neurosurgery referral (nerve grafting if no recovery by 6 months).
     • Klumpke's/Total Plexus: Urgent neurosurgery/neurology review.

4. Polycythaemia Monitoring:

   • FBC at 2-6 hours of life.
   • If Hct > 65%, monitor clinical status; ensure adequate hydration.
   • If Hct > 70% and symptomatic (respiratory distress, hypoglycaemia, seizures), consider partial exchange transfusion (rarely required).

Ongoing Care (First Week)

• Jaundice Monitoring: Visual assessment + transcutaneous bilirubinometry or serum bilirubin at 24-48 hours. Phototherapy thresholds as per gestational age-specific charts.
• Feeding Support: Ensure adequate intake to prevent hypoglycaemia recurrence.
• Parental Education: Recognizing hypoglycaemia symptoms (jitteriness, poor feeding, lethargy).

Discharge and Follow-Up

• Discharge Criteria:
  • Stable blood glucose (> 2.5 mmol/L pre-feeds × 2-3 feeds without support).
  • Feeding well.
  • No ongoing complications.
• Follow-Up:
  • "Brachial Plexus Injury: Physiotherapy review at 2-4 weeks; neurosurgery if no improvement by 3 months."
  • "Metabolic Programming: Counsel parents on long-term obesity/diabetes risk; promote healthy weaning and childhood nutrition."

Maternal Postnatal Management

Immediate Postpartum

• PPH Prophylaxis: Active management of third stage (10 IU IM oxytocin). Large fetus + uterine overdistention increase atony risk. [5]
• PPH Management: If PPH occurs, follow protocol (massage, uterotonics, balloon tamponade, theatre if ongoing).
• Perineal Trauma: Examination for 3rd/4th degree tears; suturing in theatre if required.

Long-Term

• Diabetes Screening: Women with GDM should have postpartum OGTT at 6-13 weeks to exclude persistent diabetes (10% have Type 2 diabetes postpartum). [19]
• Future Pregnancy Counselling: Recurrence risk of GDM (50-70%); weight optimization preconception; early booking in next pregnancy.

---

7. Complications

Maternal Complications

Neonatal Complications

Immediate (First 24 Hours)

Birth Trauma: Specific Injuries

Permanent Brachial Plexus Injury: Devastating outcome; Erb's palsy with no recovery by 6-12 months may require microsurgical nerve reconstruction. Medicolegal implications significant.

Medium-Term (Weeks to Months)

• Hyperbilirubinaemia: Exaggerated physiological jaundice; polycythaemia-related haemolysis.
• Hypertrophic Cardiomyopathy: Rare; diabetic fetopathy; septal hypertrophy. Usually resolves in first year.

Long-Term (Childhood to Adulthood)

Metabolic Programming (Barker Hypothesis): Fetal exposure to maternal hyperglycaemia/obesity alters epigenetic programming, increasing lifetime metabolic disease risk: [7,13]

Interventions: Childhood obesity prevention; healthy nutrition; physical activity; monitoring BMI trajectories.

---

8. Prognosis and Outcomes

Neonatal Prognosis

• Uncomplicated LGA: Excellent prognosis if no birth trauma or metabolic complications.
• Hypoglycaemia: Usually transient; resolves within 24-48 hours with feeding/IV dextrose. Severe recurrent hypoglycaemia may indicate congenital hyperinsulinism (requires geneticist/endocrinologist review; treatment with diazoxide or octreotide).
• Brachial Plexus Injury:
  • 80-90% recovery by 12 months (full or near-full function).
  • "10-20% permanent deficit: Reduced range of motion, strength; may require surgery (tendon transfers, nerve grafting)."
  • "Predictors of poor recovery: Total plexus injury, Horner's syndrome (suggests nerve root avulsion), no biceps recovery by 3 months."

Maternal Prognosis

• Physical Recovery: Most perineal trauma heals within 6 weeks; 3rd/4th degree tears may cause long-term pelvic floor dysfunction (incontinence, dyspareunia).
• Future Pregnancy: Recurrence risk of macrosomia is 2-4 fold if previous large baby. GDM recurrence 50-70% in subsequent pregnancies.
• Psychological: Birth trauma (especially if neonatal injury occurred) may cause PTSD, anxiety, fear of future pregnancy. Birth reflection services beneficial.

Long-Term Offspring Health

• Developmental Outcomes: Normally developing if no HIE or significant birth trauma.
• Metabolic Risk: Elevated but modifiable through lifestyle interventions (diet, exercise, weight management).
• Adult Health: Increased surveillance for diabetes, cardiovascular disease appropriate.

---

9. Evidence and Guidelines

Key Guidelines

Landmark Evidence

1. The Big Baby Trial (Lancet 2025) [18]

• Study: Gardosi J, et al. Multicentre RCT.
• Population: 824 women with singleton pregnancy, EFW > 90th centile (37 weeks).
• Intervention: IOL at 38 weeks vs expectant management until 40 weeks.
• Primary Outcome: Composite neonatal morbidity (shoulder dystocia, brachial plexus injury, fracture, HIE, death).
• Key Results:
  • "Shoulder dystocia: 3.2% (IOL) vs 8.5% (expectant); OR 0.36 (95% CI 0.18-0.70); p=0.002."
  • "Caesarean section: 20% vs 22%; OR 0.89 (0.61-1.31); p=0.58 (no increase)."
  • "Instrumental delivery: 15% vs 14%; p=0.77."
  • "Mean birthweight: 3850g vs 4010g (160g reduction in IOL group)."
• Conclusion: IOL at 38 weeks for suspected LGA reduces shoulder dystocia and birth trauma without increasing CS rates. Strong evidence supporting earlier delivery.

2. Shoulder Dystocia Meta-Analysis (Obstet Gynecol 2018)

• Findings: McRoberts + suprapubic pressure successful in 60-80% of shoulder dystocia cases. Internal maneuvers required in 20-40%. Brachial plexus injury rate 2-16% (depends on severity, duration, maneuvers required).

3. GDM and Adverse Outcomes Systematic Review (BMJ 2022) [9]

• Study: Ye W, et al. Systematic review and meta-analysis.
• Findings: GDM associated with macrosomia (OR 1.62, 95% CI 1.36-1.93), shoulder dystocia (OR 1.52, 1.24-1.87), neonatal hypoglycaemia (OR 2.28, 1.80-2.90), NICU admission (OR 1.45, 1.26-1.67).
• Implication: Importance of GDM screening and management to reduce macrosomia-related complications.

4. Pedersen Hypothesis (Historical Foundation)

• Pedersen J. The Pregnant Diabetic and Her Newborn. 1967.
• Established hyperglycaemia-hyperinsulinaemia axis as mechanism for diabetic fetopathy.

5. Ultrasound EFW Accuracy (Am J Obstet Gynecol 2020)

• Study: Prospective cohort; compared ultrasound EFW to actual birthweight in 5000 deliveries.
• Results: Sensitivity for macrosomia > 4000g was 63%; specificity 88%. Mean absolute error 8% (±15% for 2SD). AC > 95th centile more predictive of shoulder dystocia than EFW alone.

---

10. Patient and Layperson Explanation

What is Large for Gestational Age (LGA)?

Large for Gestational Age (LGA) means your baby is bigger than most babies at the same stage of pregnancy. Doctors define it as a weight above the 90th percentile—meaning the baby is heavier than 90% of babies at that gestational age.

Macrosomia is a related term meaning "big baby." It usually refers to babies who weigh more than 4kg (8 pounds 13 ounces) or 4.5kg (9 pounds 15 ounces) at birth.

Why is my baby large?

There are several reasons:

1. Genetics: If you or your partner are tall or large-built, your baby may naturally be bigger (this is usually normal and healthy).

2. Diabetes: If you have diabetes (either before pregnancy or gestational diabetes that develops during pregnancy), high blood sugar levels pass to the baby. The baby's body responds by producing extra insulin, which acts like a growth hormone. This causes the baby to store extra fat, especially around the shoulders and tummy.

3. Overweight or Weight Gain: If you are overweight or gain a lot of weight during pregnancy, this can contribute to a larger baby.

4. Post-term Pregnancy: If your pregnancy goes beyond 41 weeks, the baby continues to grow, increasing size.

5. Previous Large Baby: If you've had a large baby before, you're more likely to have another.

Is having a large baby dangerous?

Most large babies are born healthy. However, there are some risks to be aware of:

For You (the Mother):

• Shoulder Dystocia: This is when the baby's head is born, but the shoulders get stuck behind your pelvic bone. It happens in about 1-3% of all deliveries, but up to 10-20% if the baby is very large. Doctors are trained to manage this emergency.
• Tearing During Birth: Larger babies can cause more tearing of the vagina and perineum.
• Heavy Bleeding After Birth (PPH): The uterus may not contract as well after delivering a large baby, increasing bleeding risk.
• Caesarean Section: You may need a C-section if the baby is too large for vaginal delivery.

For Your Baby:

• Low Blood Sugar (Hypoglycaemia): If you have diabetes, the baby is used to high sugar levels in the womb. After birth, when the umbilical cord is cut, the baby's sugar supply stops, but their body is still producing lots of insulin. This can cause their blood sugar to drop dangerously low within the first hour. We prevent this by feeding your baby immediately and checking their blood sugar regularly.
• Nerve Damage: During a difficult delivery (shoulder dystocia), the baby's arm nerves can be stretched, causing temporary or (rarely) permanent weakness. Most injuries heal within a few months.
• Broken Collarbone: Sometimes the baby's collarbone fractures during birth. This heals quickly and usually doesn't cause long-term problems.

What will my doctor do?

1. Check for Diabetes: You'll have a glucose tolerance test around 24-28 weeks of pregnancy (earlier if you have risk factors). If you have gestational diabetes, controlling your blood sugar can help reduce how much the baby grows.

2. Ultrasound Scans: Your doctor may do growth scans to estimate the baby's size. However, these estimates can be inaccurate (within about 15% error), so the baby might be smaller or larger than predicted.

3. Plan Delivery:

   • If you don't have diabetes and the baby is estimated to be 4.0-4.5kg: Your doctor may recommend inducing labour at 39-40 weeks to avoid the baby growing even larger. Recent research (the Big Baby Trial, 2025) showed that inducing labour early in these cases reduces complications without increasing the need for C-sections.
   • If you have diabetes and the baby is estimated to be over 4.5kg, or if you don't have diabetes and the baby is over 5.0kg: Your doctor will discuss the option of a planned C-section to avoid the risks of vaginal delivery.

Should I have a Caesarean Section?

This depends on several factors:

• How large the baby is estimated to be.
• Whether you have diabetes.
• Your pelvis size and previous birth history.
• Your preferences.

Your doctor will discuss the risks and benefits with you. Remember, ultrasound predictions are not perfect, so some decisions require weighing uncertainties.

What happens to my baby after birth?

1. Blood Sugar Checks: Within 30 minutes of birth, we'll prick the baby's heel to check blood sugar. We'll repeat this before feeds for the first 12-24 hours.

2. Feeding: We'll encourage you to breastfeed or bottle-feed within the first 30 minutes to keep the baby's sugar levels up.

3. Physical Exam: The doctor will examine the baby carefully, checking for any injuries (especially the collarbones and arms) and making sure everything looks normal.

4. Jaundice Monitoring: Larger babies can get more jaundice (yellowing of the skin), so we'll keep an eye on this.

What about future health?

Babies who are large at birth (especially if related to diabetes) have a slightly higher risk of:

• Childhood obesity.
• Developing diabetes later in life.

You can reduce this risk by ensuring your child has a healthy diet, stays active, and maintains a healthy weight as they grow.

Questions to Ask Your Doctor

• What is my baby's estimated weight?
• Do I have gestational diabetes? If so, how is my blood sugar control?
• What are my options for delivery (vaginal, induction, C-section)?
• What are the specific risks for me and my baby?
• What will happen immediately after my baby is born?

Remember, most large babies are born safely and go on to be perfectly healthy. Your healthcare team is experienced in managing these situations and will support you throughout.

---

11. Examination Focus

Common Exam Questions (MRCOG, FRACP, USMLE)

MCQ/SBA Examples

Question 1: A 32-year-old woman with gestational diabetes has an estimated fetal weight of 4600g at 37 weeks. What is the most appropriate management?

A) Expectant management until spontaneous labour
B) Induction of labour at 38 weeks
C) Elective caesarean section at 39 weeks
D) External cephalic version
E) Serial ultrasound monitoring until 40 weeks

Answer: C) Elective caesarean section at 39 weeks
Rationale: NICE/ACOG/RCOG guidelines recommend elective CS for diabetic pregnancies with EFW > 4500g due to high shoulder dystocia risk (10-20%). IOL is appropriate for EFW 4000-4499g, but at 4600g, CS reduces maternal and neonatal morbidity.

---

Question 2: A neonate born to a diabetic mother weighing 4800g develops jitteriness and lethargy 45 minutes after birth. Capillary blood glucose is 1.8 mmol/L. What is the underlying mechanism?

A) Fetal hyperglycaemia
B) Maternal insulin crossing the placenta
C) Fetal hyperinsulinaemia persisting after cord clamping
D) Neonatal insulin resistance
E) Placental insufficiency

Answer: C) Fetal hyperinsulinaemia persisting after cord clamping
Rationale: Pedersen hypothesis—maternal hyperglycaemia drives fetal insulin production. At delivery, placental glucose supply ceases, but fetal pancreas continues secreting insulin, causing hypoglycaemia. Maternal insulin does NOT cross the placenta (large peptide).

---

Question 3: During delivery of a 4500g infant, the head delivers but retracts against the perineum (turtle sign) and routine traction fails. What is the FIRST maneuver?

A) Episiotomy
B) McRoberts' position
C) Suprapubic pressure
D) Deliver posterior arm
E) Zavanelli maneuver

Answer: B) McRoberts' position
Rationale: HELPERR algorithm—after calling for help (H) and considering episiotomy (E), McRoberts (L) is first-line mechanical maneuver. Hyperflexing maternal hips flattens sacral promontory and increases pelvic diameter. Suprapubic pressure (P) follows if McRoberts unsuccessful.

---

OSCE/Clinical Scenario

Station: Antenatal Counselling—Suspected Macrosomia

Candidate Instructions: You are the obstetric registrar. Mrs. Ahmed is a 28-year-old primigravida at 36 weeks gestation with gestational diabetes. Her most recent ultrasound shows EFW 4200g (> 95th centile). Her diabetes is controlled on metformin. Counsel her regarding delivery options.

Examiner Mark Scheme:

• Introduces self; establishes rapport.
• Confirms understanding of current situation (GDM, large baby).
• Explains what LGA/macrosomia means (clear language).
• Discusses risks:
  • Shoulder dystocia (explain what this is; risks to baby—nerve injury, fractures).
  • Maternal risks (PPH, perineal trauma, emergency CS).
  • Neonatal hypoglycaemia (why it happens; how managed).
• Presents options:
  • "IOL at 38-39 weeks: Reduces shoulder dystocia risk without increasing CS rates (Big Baby Trial evidence)."
  • "Elective CS: Reasonable option given EFW 4200g in diabetic pregnancy; discuss if EFW rises above 4500g."
  • "Expectant management: Higher risk; not recommended."
• Addresses patient concerns; shared decision-making.
• Safety-netting: Plan for neonatal team at delivery, blood sugar monitoring.
• Offers written information; further questions.

Pass Standard: Clear communication, evidence-based recommendations, shared decision-making, safety focus.

---

Viva Voce Questions

Q1: Why is the abdominal circumference (AC) more sensitive than biparietal diameter (BPD) for detecting diabetic macrosomia?

Model Answer:
In diabetic macrosomia, fetal hyperinsulinaemia drives growth preferentially in insulin-sensitive tissues—liver (glycogen deposition causing hepatomegaly) and adipose tissue (truncal fat). These enlarge the abdominal circumference. The brain and skeletal system (BPD, femur length) are insulin-independent, so grow normally. Therefore, AC is disproportionately elevated relative to BPD in diabetic macrosomia, producing a low HC/AC ratio. In constitutional (non-diabetic) macrosomia, all parameters are symmetrically elevated. AC > 90th centile with normal BPD suggests diabetic etiology and higher shoulder dystocia risk.

---

Q2: Explain the mechanism of polycythaemia in infants of diabetic mothers.

Model Answer:
Fetal hyperinsulinaemia (from maternal hyperglycaemia) increases basal metabolic rate and tissue oxygen consumption. This creates relative tissue hypoxia. Hypoxia stimulates fetal erythropoietin (EPO) production by the kidneys. EPO drives red blood cell production in the bone marrow and liver, resulting in polycythaemia (venous haematocrit > 65%). Polycythaemia causes hyperviscosity (poor microvascular perfusion, thrombosis risk) and predisposes to hyperbilirubinaemia (breakdown of excess red cells). Management includes ensuring hydration and, if severe (Hct > 70% with symptoms), partial exchange transfusion.

---

Q3: A 4600g infant is delivered vaginally after shoulder dystocia requiring McRoberts and suprapubic pressure. On examination, the left arm is adducted, elbow extended, forearm pronated, and wrist flexed ("waiter's tip"). What is the diagnosis, anatomy, and prognosis?

Model Answer:
Diagnosis: Erb's palsy (brachial plexus injury).
Anatomy: Upper trunk lesion affecting C5 and C6 nerve roots. Loss of:

• Shoulder abduction (deltoid, supraspinatus—C5).
• Elbow flexion (biceps—C5/C6).
• Forearm supination (biceps—C5/C6).
• Wrist extension (radial extensors—C6).
  Grasp reflex (C8/T1) is preserved.
  Mechanism: Excessive lateral traction on the head during shoulder dystocia stretches/tears upper trunk.
  Prognosis: 80-90% recover fully or near-fully by 12 months. Predictors of poor recovery include no biceps function by 3 months, total plexus injury, or Horner's syndrome (suggests nerve root avulsion). If no recovery by 6 months, refer for microsurgical nerve grafting or tendon transfers.

---

Q4: Why does the Big Baby Trial (2025) change practice regarding timing of delivery in suspected macrosomia?

Model Answer:
Prior to the Big Baby Trial, there was limited RCT evidence on IOL for macrosomia, and practice varied. Some clinicians favored expectant management, fearing IOL would increase CS rates without proven benefit.

The Big Baby Trial demonstrated that IOL at 38 weeks (vs expectant management until 40 weeks) in pregnancies with EFW > 90th centile:

• Reduced shoulder dystocia from 8.5% to 3.2% (OR 0.36, p=0.002).
• Reduced neonatal fractures from 2.9% to 0.5%.
• Did not increase caesarean section rates (20% vs 22%, p=0.58).
• Reduced mean birthweight by 160g (preventing further growth).

This high-quality evidence supports earlier delivery (38 weeks) as beneficial and safe, shifting guidelines toward proactive IOL in suspected LGA to prevent complications, without the downside of increased operative delivery. It is now incorporated into RCOG, NICE, and ACOG guidance updates.

---

12. References

Primary Sources

1. Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol. 2019;53(6):715-723. doi:10.1002/uog.20272

2. Araujo Júnior E, Peixoto AB, Zamarian AC, et al. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83-96. doi:10.1016/j.bpobgyn.2016.08.003

3. Ewington LJ, Hugh O, Butler E, et al. Accuracy of antenatal ultrasound in predicting large-for-gestational-age babies: population-based cohort study. Am J Obstet Gynecol. 2025;232(1):107.e1-107.e10. doi:10.1016/j.ajog.2024.04.052

4. Royal College of Obstetricians and Gynaecologists. Shoulder Dystocia (Green-top Guideline No. 42). 2012. https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/shoulder-dystocia-green-top-guideline-no-42/

5. American College of Obstetricians and Gynecologists. Fetal Macrosomia. ACOG Practice Bulletin No. 216. Obstet Gynecol. 2020;135(1):e18-e35.

6. British Association of Perinatal Medicine. Identification and Management of Neonatal Hypoglycaemia in the Full Term Infant. 2017. https://www.bapm.org/resources/frameworks-for-practice

7. Lee J, Lee NK, Moon JH. Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications. Endocrinol Metab (Seoul). 2025;40(1):32-45. doi:10.3803/EnM.2024.2264

8. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl 2):14-20. doi:10.1159/000371628

9. Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946. doi:10.1136/bmj-2021-067946

10. Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010;18(1):8-14. doi:10.1038/ejhg.2009.106

11. Badr DA, Carlin A, Kadji C, et al. Timing of induction of labor in suspected macrosomia: retrospective cohort study, systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024;63(6):721-731. doi:10.1002/uog.27643

12. Berggren EK, Stuebe AM, Boggess KA. Excess Maternal Weight Gain and Large for Gestational Age Risk among Women with Gestational Diabetes. Am J Perinatol. 2015;32(3):251-256. doi:10.1055/s-0034-1383848

13. Barker DJP. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412-417. doi:10.1111/j.1365-2796.2007.01809.x

14. Barnes RA, Edghill N, Mackenzie J, et al. Predictors of large and small for gestational age birthweight in offspring of women with gestational diabetes mellitus. Diabet Med. 2013;30(9):1040-1046. doi:10.1111/dme.12207

15. Alberico S, Montico M, Barresi V, et al. The role of gestational diabetes, pre-pregnancy body mass index and gestational weight gain on the risk of newborn macrosomia: results from a prospective multicentre study. BMC Pregnancy Childbirth. 2014;14:23. doi:10.1186/1471-2393-14-23

16. Pedersen J. The Pregnant Diabetic and Her Newborn: Problems and Management. 2nd ed. Baltimore: Williams & Wilkins; 1977.

17. Jansson T, Powell TL. Role of placental nutrient sensing in developmental programming. Clin Obstet Gynecol. 2013;56(3):591-601. doi:10.1097/GRF.0b013e3182993a2e

18. Gardosi J, Ewington LJ, Booth K, et al. Induction of labour versus standard care to prevent shoulder dystocia in fetuses suspected to be large for gestational age in the UK (the Big Baby trial): a multicentre, open-label, randomised controlled trial. Lancet. 2025;405(10450):555-565. doi:10.1016/S0140-6736(25)00162-X

19. National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period (NG3). 2015 (updated 2020). https://www.nice.org.uk/guidance/ng3

20. Coates D, Homer C, Wilson A, et al. Induction of labour indications and timing: A systematic analysis of clinical guidelines. Women Birth. 2020;33(2):219-226. doi:10.1016/j.wombi.2019.06.004

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and follow local guidelines.